Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Concord Biotech Ltd.
₹1,059
Invest in CONCORDBIO with up to 2.50x margin.
Trade with MTF₹1046.40
₹1094.20
₹987.00
₹2150.40
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 278.13 | 247.06 | 203.99 | 429.88 | 244.22 |
| Operating Expense | 175.91 | 156.52 | 142.59 | 239.46 | 146.27 |
| Operating Profit | 102.22 | 90.54 | 61.40 | 190.42 | 97.95 |
| Depreciation | 18.67 | 18.39 | 17.78 | 14.62 | 13.26 |
| Interest | 0.06 | 0.06 | 0.06 | 0.10 | 0.10 |
| Tax | 22.51 | 22.62 | 14.67 | 43.16 | 25.23 |
| Net Profit | 67.78 | 62.90 | 42.57 | 141.94 | 74.09 |
₹1059.00
↗ Bullish Moving Average
5
↘ Bearish Moving Average
11
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 44.1 | 44.1 | 44.1 | 44.1 | 44.1 | 44.1 |
| FII | 8.1 | 8.3 | 9.4 | 9.1 | 8 | 7.6 |
| DII | 9.9 | 9.7 | 9.1 | 8.9 | 9.6 | 9.6 |
| Public | 38 | 37.9 | 37.4 | 37.9 | 38.3 | 38.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.47 L | 2.69 L | 54.70% |
| Week | 1.34 L | 2.25 L | 59.32% |
| 1 Month | 1.03 L | 2.15 L | 47.83% |
| 6 Month | 76.01 K | 3.06 L | 24.86% |
Benjamin Graham Value Screen
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 03 Sep, 2025 | 10.7 | FINAL | 03 Sep, 2025 | Equity Share |
| 21 Jun, 2024 | 8.75 | FINAL | 22 Jun, 2024 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,565 | ₹613.90 | ₹864 | ₹1,370 | ₹4,550 | ₹492.20 |
| % Change | 0.66% | -0.35% | 8.20% | 1.97% | 1.57% | -2.52% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹1,419.33 | ₹878.40 | ₹4,256.70 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹20.10 | ₹240.10 | ₹318.19 |
| PE TTM | - | - | 68.60 | 784.40 | 43.80 | 24.30 |
| 1 Year Return | 47.07 | 3.42 | 76.54 | -11.44 | -6.21 | 10.23 |
| ROCE | 30.24 | 34.78 | 34.76 | 3.26 | - | 11.27 |
Blue Jet Healthcare Ltd
₹ 370.00
-1.20%
Aarti Pharmalabs Ltd.
₹ 679.00
-1.34%
Piramal Pharma Ltd.
₹ 143.50
-0.19%
Supriya Lifescience Ltd.
₹ 626.70
-1.61%
Acutaas Chemicals Ltd.
₹ 2339.80
+0.17%
Alivus Life Sciences Ltd.
₹ 1040.55
-0.35%
Cohance Lifesciences Ltd.
₹ 320.00
+3.39%
Eris Lifesciences Ltd.
₹ 1364.00
+1.04%
Syngene International Ltd.
₹ 394.50
-1.14%
Alembic Pharmaceuticals Ltd.
₹ 720.00
-0.86%
Strides Pharma Science Ltd.
₹ 995.00
+3.17%
Granules India Ltd.
₹ 634.20
-1.57%
FDC Ltd.
₹ 341.50
-1.26%
Shilpa Medicare Ltd.
₹ 418.65
+3.70%
Jubilant Pharmova Ltd.
₹ 871.85
-0.67%
Natco Pharma Ltd.
₹ 1127.00
+1.31%
Caplin Point Laboratories Ltd.
₹ 1659.90
-0.02%
Neuland Laboratories Ltd.
₹ 14726.00
+4.77%
Marksans Pharma Ltd.
₹ 174.90
+0.17%
AstraZeneca Pharma India Ltd.
₹ 8050.00
+2.03%
Sanofi India Ltd.
₹ 3450.00
+0.89%
Procter & Gamble Health Ltd.
₹ 4800.00
-0.90%
Jeena Sikho Lifecare Ltd.
₹ 650.70
-0.75%
By signing up I certify terms, conditions & privacy policy